Scandinavian ChemoTech receives a new patent on the Japanese market
Scandinavian ChemoTech has been notified that the patent authority in Japan has approved the Company's patent relating to the unique IQwave™, vetIQure™, probe and the unique electrodes that the TSE™ treatment kit consists of.The approved patent protects both the unique probe, which the doctor and veterinarian hold, as well as the unique electrodes (needles) that are used to deliver the dynamic and tumour specific pulse in the treatment of patients.
The probe has unique properties that allow you to adjust how large an area you want to treat. Because the electrodes can be attached in